EUCTR2019-001118-40-NL进行中（未招募）1 期
Response to pneumococcal polysaccharide vaccination in healthy adults
Department of Pulmonology0 个研究点目标入组 210 人开始时间: 2019年8月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Age =18 years and =80 years
- •Fits within pre-specified age and gender stratification blocks
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 160
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Previous vaccination with pneumococcal polysaccharide or conjugate vaccination
- •Chronic disease that requires the use of immunosuppressive agents
- •Known or highly suspected primary or secondary immunodeficiency
- •Fever or active infection
- •History of allergic reaction to one of the vaccine components
- •No informed consent
研究者
相似试验
招募中
不适用
Response to pneumococcal polysaccharide vaccination in healthy adultsimmunodeficiencyNL-OMON55592Sint Antonius Ziekenhuis210
进行中（未招募）
3 期
Australian Study for the Prevention through Immunisation of Cardiovascular EventsStrokeMyocardial InfarctionCardiovascular DiseaseACTRN12615000536561niversity of Newcastle4,725
进行中（未招募）
1 期
Immune response test as new predictor for successful TKI stop in patients with chronic myeloid leukemiaChronic myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10009016Term: Chronic myeloid leukemia in remissionSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10009015Term: Chronic myeloid leukemiaSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864EUCTR2020-002850-26-NLAlbert Schweitzer Hospital57
招募中
不适用
Vaccination response to pneumococcal antigen as novel predictor for successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.NL-OMON55091Albert Schweitzer Ziekenhuis57
招募中
不适用
De antistof respons na pneumokokkenvaccinatie bij IBD-patiënten die behandeld worden met immunosuppressiva – de PNEUMOREACT studieinflammatory bowel disease (inflammatoire darmziekte)immunosuppressive agents (immunosuppressiva)pneumococcal vaccination (pneumokokkenvaccinatie)vaccine immunogenicity (vaccin immunogeniciteit)NL-OMON29135Academic Medical Center188